Daniel Chubb

Institute of Cancer Research — United Kingdom

Medicine · Health Sciences

33h-index5.5kcitations110works38.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Reconstructive Surgery and Microvascular Techniques(36), Cancer Genomics and Diagnostics(32), Genetic factors in colorectal cancer(22), Reconstructive Facial Surgery Techniques(22), Bone fractures and treatments(14)

Publications110 total

Quantifying evidence for phenotypic specificity (PP4) for syndromic phenotypes: Large-scale integration of rare germline FH variants from diagnostic laboratory testing for HLRCC and renal cancer
Genetics in Medicine·2025Open Access
Genomic landscape of diffuse glioma revealed by whole genome sequencing
Nature Communications·2025· 4 citedOpen Access
The genomic landscape of 2,023 colorectal cancers
Nature·2024· 123 citedOpen Access
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
Nature Communications·2024· 13 citedOpen Access
Postoperative anaemia increases unplanned readmission: an international prospective cohort study of patients undergoing major abdominal surgery
British journal of surgery·2024· 7 citedOpen Access
Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology
Nature Genetics·2024· 47 citedOpen Access
Genetic landscape of interval and screen detected breast cancer
npj Precision Oncology·2024· 3 citedOpen Access
Whole genome sequencing reveals differences in the genetic landscape of interval and screen-detected breast cancer
Research Square (Research Square)·2024Open Access
Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme
Nature Medicine·2024· 148 citedOpen Access
Genomic landscape of diffuse glioma revealed by whole genome sequencing
2023Open Access
Cancer driver genes and opportunities for precision oncology revealed by whole genome sequencing 10,478 cancers
2023Open Access
Whole-genome sequencing uncovers the genomic determinants of therapeutic resistance to immune checkpoint blockade
Research Square (Research Square)·2023Open Access
Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients
2023· 21 citedOpen Access
Small bowel obstruction secondary to Meckel's diverticulum impacted with phytobezoar
ANZ Journal of Surgery·2023· 1 citedOpen Access
Cancer driver genes and opportunities for precision oncology revealed by whole genome sequencing 10,478 cancers
2023· 3 citedOpen Access
Insights for precision healthcare from the 100,000 Genomes Cancer Programme
Research Square (Research Square)·2022· 1 citedOpen Access
Whole genome sequencing of 2,023 colorectal cancers reveals mutational landscapes, new driver genes and immune interactions
2022· 3 citedOpen Access
Whole genome sequencing of 2,023 colorectal cancers reveals mutational landscapes, new driver genes and immune interactions
2022· 9 citedOpen Access
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features
Nature Genetics·2022· 70 citedOpen Access
Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline
Nature·2022· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Richard S. Houlston(24), Mark W. Ashton(16), Warren M. Rozen(15), Sara E. Dobbins(14), Ben Kinnersley(12), Peter Broderick(11), Iain S. Whitaker(11), Alex J. Cornish(11), Ian Tomlinson(8), Amy L. Sherborne(7), Damien Grinsell(7), Philip Law(6), Claire Palles(5), P. Yussanne(5), Gareth J. Morgan(5), Andreas Gruber(5), David C. Wedge(5), Amy Lloyd(4), Clare Turnbull(4), Niels Weinhold(4)